In(III)-Catalyzed 1,2-Hydrophosphorylation of 3-Alkynyl-3-hydroxyisoindolinones to 3,3-Disubstituted Isoindolinones Featuring Both Phosphoryl and Alkynyl Groups at the C3-Position.

J Org Chem

Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, 2025 Chengluo Avenue, Chengdu 610016, P. R. China.

Published: February 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We report a highly regioselective 1,2-addition of P(O)-H compounds to the in situ generated β,γ-alkynyl-α-ketimine derived from 3-alkynyl-3-hydroxyisoindolinones, which provided a general protocol for the preparation of 3,3-disubstituted isoindolinones featuring both phosphoryl and alkynyl groups at a quaternary carbon center. The use of only 2-5 mol % of an inexpensive catalyst (In(ClO)·8HO or Bi(OTf)) allowed the smooth output of the desired products under mild conditions (25 °C, 0.5-24 h) with a broad substrate scope (35 examples) in up to >99% yield. The obtained products could be further elaborated based on the alkyne moiety. The initial asymmetric trial indicated that the use of BINOL-derived CPA could enable an enantioselective induction in up to a 46% yield with 77% ee.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.4c02035DOI Listing

Publication Analysis

Top Keywords

33-disubstituted isoindolinones
8
isoindolinones featuring
8
featuring phosphoryl
8
phosphoryl alkynyl
8
alkynyl groups
8
iniii-catalyzed 12-hydrophosphorylation
4
12-hydrophosphorylation 3-alkynyl-3-hydroxyisoindolinones
4
3-alkynyl-3-hydroxyisoindolinones 33-disubstituted
4
groups c3-position
4
c3-position report
4

Similar Publications

A highly efficient tetrabutylammonium decatungstate (TBADT)-catalyzed synthesis of isoindolinones using activated alkenes and alcohols/ethers hydrogen atom transfer process was developed. A variety of functionalized isoindolinones were obtained in good yields with high selectivity and broad functional group tolerance.

View Article and Find Full Text PDF

Novel Isoindolinone-Containing PARP Inhibitors: Synthesis and Therapeutic Applications in CNS Cancer Treatment.

ACS Med Chem Lett

August 2025

Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.

This patent discloses the development and therapeutic applications of novel poly-(ADP-ribose) polymerase (PARP) inhibitors featuring an isoindolinone scaffold. These isoindolinone-based PARP inhibitors represent a strategically designed class of central nerve system (CNS) cancer therapeutics that combine potent PARP inhibitory activity with enhanced blood-brain barrier (BBB) permeability.

View Article and Find Full Text PDF

An alternative and unique approach for synthesizing 3-substituted isoindolinones Lewis acid-catalyzed C-C bond-breaking reactions has been reported. For this purpose, we successfully generated -acyliminium ion intermediates from two different substrates [through (a) an FeCl catalyzed C-C bond-breaking reaction in isoindolinones bearing electron-rich and sterically bulky aryl substituents at the 3-position and (b) a ZnCl catalyzed C-C bond-breaking reaction in isoindolinones bearing 1,3-diketo substituents at the 3-position of the isoindolinone starting precursors], which were trapped by appropriate nucleophiles to produce more stable γ-substituted isoindolinones in good to excellent yields. The leaving ability of 1,3-diketones is higher than that of electron-rich and sterically bulky arenes in our developed method, which results in higher yields of γ-substituted isoindolinones from the starting precursor bearing the 1,3-diketo substituents at its 3-position.

View Article and Find Full Text PDF

Diuretics are commonly used in doping because they can conceal the presence of performance-enhancing substances in an athlete's urine through dilution and promote rapid weight loss. As a result, these substances are prohibited in sports by the World Anti-Doping Agency (WADA) under the S5 category ("Diuretics and Masking Agents"). Chlorthalidone, a thiazide-like diuretic, is medically used as an antihypertensive agent and is prescribed for conditions such as heart failure and liver cirrhosis.

View Article and Find Full Text PDF

Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates.

J Med Chem

July 2025

CHDI Management, Inc., The Company That Manages the Scientific Activities of CHDI Foundation, Inc., 6080 Center Drive, Suite 700, Los Angeles, California 90045, United States.

Huntington's disease (HD) is caused by the repeat expansion of the CAG trinucleotide in the mutant Huntingtin gene (m) within the exon1 region, resulting in an expanded polyglutamine-containing mHTT exon1 protein that serves as the source of the hallmark mHTT aggregates in people with HD (PwHD). To better understand aggregation formation during disease progression and its utility as a pharmacodynamic biomarker, we have been targeting mHTT aggregates for developing PET imaging tracers and have identified a series of isoindolinones that show significantly higher binding potential (BP, a ratio of Bmax over ) in HD mouse models as well as increased binding in HD post-mortem brains, compared to first generation ligands. We present the structure-activity relationship (SAR) work leading to three candidate tracers progressed for human studies: [C]CHDI-009 (), [F]CHDI-385 () and [F]CHDI-386 ().

View Article and Find Full Text PDF